Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | CETP | P11597 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.32 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.32 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.32 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6057094 | 0.88 | CETP (0.39) | SLC1A3SLC1A2SLC1A1CETPALOX5 | |
| SCHEMBL17163832 | 0.83 | SLC1A3 (0.42) | SLC1A3SLC1A2SLC1A1CETPALOX5 | |
| SCHEMBL1145281 | 0.74 | — | — | |
| SCHEMBL3059807 | 0.74 | — | — | |
| SCHEMBL22593308 | 0.74 | — | — | |
| SCHEMBL13744903 | 0.74 | — | — | |
| SCHEMBL1145283 | 0.74 | — | — | |
| SCHEMBL16254194 | 0.74 | — | — | |
| SCHEMBL12417069 | 0.71 | — | — | |
| SCHEMBL12853955 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3129199-B1 | CHEMICALLY MODIFIED WOOD AND NON-WOOD PRODUCTS AND METHODS FOR THE PRODUCTION THEREOF | HERMESCEC BRANKO (CN) | 2019-08-07 | — | — | EP | disclosed |
| US-20160144531-A1 | CHEMICALLY MODIFIED WOOD AND NON-WOOD PRODUCTS AND METHODS FOR THE PRODUCTION THEREOF | HERMESCEC, BRANKO (CN) | 2016-05-26 | — | — | US | disclosed |
| US-20160144531-A1 | CHEMICALLY MODIFIED WOOD AND NON-WOOD PRODUCTS AND METHODS FOR THE PRODUCTION THEREOF | HERMESCEC, BRANKO (CN) | 2016-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160144531-A1 | CHEMICALLY MODIFIED WOOD AND NON-WOOD PRODUCTS AND METHODS FOR THE PRODUCTION THEREOF | ME3, ME1, DCXR | SLC1A3 4740/4885SLC1A2 4883/4885SLC1A1 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.